Showing results (411-420 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|May 16, 2013
Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individualsBenjamin Rolland, Pierre Alexis Geoffroy, Renaud Jardri, et al.Clinical Neuropharmacology|June 1, 1990
Effects of atropine on learning and memory functions in dementiaR Inzelberg, T Shapira, A D KorczynClinical Neuropharmacology|February 24, 2012
Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepinessClara Inocente, Isabelle Arnulf, Hélène Bastuji, et al.Clinical Neuropharmacology|September 18, 2014
Long-term retention rate of zonisamide in patients with epilepsy: an observational studyDong Wook Kim, Kyomin Choi, Heui-Soo Moon, et al.Clinical Neuropharmacology|September 18, 2014
Topiramate-associated urinary incontinence: a case verified by rechallengeCheng-Fa Wang, Pei-Shen Ho, Yu-Ting Tseng, et al.Clinical Neuropharmacology|September 18, 2014
Sensorimotor polyneuropathy after a 1-month treatment with oral acitretinElisabeth Chroni, Alexandra Monastirli, Sophia Georgiou, et al.Clinical Neuropharmacology|August 1, 1989
Carbamazepine-induced ticsR Kurlan, J Kersun, J Behr, et al.Clinical Neuropharmacology|June 21, 2013
Acute Pisa syndrome after administration of a single dose of mirtazapineAntonio Méndez Guerrero, Sara Llamas, Francisco José Murcia, et al.Clinical Neuropharmacology|June 21, 2013
Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter studyClaudio Solaro, Roberto Bergamaschi, Cristiana Rezzani, et al.Clinical Neuropharmacology|January 1, 1990
Evidence for a linear relationship between plasma trazodone levels and clinical response in depression in the elderlyP Monteleone, G GnocchiPageof 236